Daniel J. Leal Alviarez, MD
Department of Hospital Medicine, Division of Internal Medicine
Present Title & Affiliation
Primary Appointment
Assistant Professor, Department of Hospital Medicine, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Assistant Professor, Department of Hospital Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 2018 | Universidad Central del Caribe, Bayamon, PR, MD |
| 2014 | University of Puerto Rico at Bayamon, Bayamon, PR, Natural Sciences / Human Biology, BS |
Postgraduate Training
| 2018-2021 | Clinical Residency, Baylor College of Medicine/MD Anderson Cancer Center, Houston, Texas |
| 2014-2018 | Clinical Residency, Substance Abuse Medicine, Universidad Central del Caribe, Bayamon |
Licenses & Certifications
| 2024 | ACLS |
| 2024 | BLS |
| 2021 | American Board of Internal Medicine |
| 2020 | DEA |
| 2020 | Texas Medical License |
Experience & Service
Faculty Academic Appointments
Instructor, Department of Hospital Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2021 - 2024
Other Professional Positions
Patient Safety Quality Officer, The University of Texas MD Anderson Cancer Center, 2025 - Present
Extramural Institutional Committee Activities
Member, Medication Related Clinical Decision Support Subcommittee, The University of Texas MD Anderson Cancer Center, 2021 - Present
Honors & Awards
| 2024 | November 2024 Excellence in Safety Award, MD Anderson Team up for Safety |
| 2023 | 1st Place on Quality Improvement and Patient Safety Project, MD Anderson Cancer Center, Division of Internal Medicine Research Retreat Poster Session |
| 2016 | Alpha Omega Alpha, Gamma chapter inductee, Universidad Central del Caribe, Bayamon, Puerto Rico |
| 2015 - 2018 | Academic Excellence Scholarship, Universidad Central del Caribe, Bayamon, Puerto Rico |
Professional Memberships
Selected Presentations & Talks
Local Presentations
- 2023. Hepatorenal Syndrome. Presented for the Advanced Practice Providers (APP) education series. Conference. The University of Texas MD Anderson Cancer Center, Houston, TX. Houston, TX, US.
- 2022. Diagnosis and Management to Immune Checkpoint Inhibitor (ICI)-Related Pneumonitis on the Hospitalist Service: DHM iTox QI Project 2.0. Conference. Department of Hospital Medicine. Houston, TX, US.
- 2021. Challenging Cases - Patient Care Review. Conference. The University of Texas MD Anderson Cancer Center. Houston, TX, US.
- 2021. High Value Care. Conference. Morning Report Conference. Houston, TX, US.
- 2020. Alarm Safety and Alarm Fatigue. Conference. Interdisciplinary Morbidity and Mortality Conference. Houston, TX, US.
- 2020. High Value Care. Conference. Morning Report Conference. Houston, TX, US.
- 2019. Anticoagulation and Brain Metastasis. Conference. Interdisciplinary Morbidity and Mortality Conference. Houston, TX, US.
- 2019. High Value Care. Conference. Morning Report Conference. Houston, TX, US.
National Presentations
- 2019. Rivaroxaban Induced Hypersensitivity Syndrome. Conference. Poster presented at Society of Hospital Medicine Annual Meeting. National Harbor, MD, US.
Selected Publications
Peer-Reviewed Articles
- Simbaqueba Clavijo, CA, Odaro, OE, Gandhi, A, Koom-Dadzie, K, Musaelyan, A, Dickson, KB, Chua, R, Bhise, VR, Amoateng, MD, Tomy, S, Leal Alviarez, DJ, Phyu, EM, Bogdanich, I, Andersen, C, Sheshadri, A, Palaskas, NL, Halm, J, Manzano, JM. Immunotherapy-Related Adverse Events and Clinical Outcomes in Adult Solid-Tumor Patients Admitted to an Onco-Hospitalist Medicine Service. Cancers 17(3), 2025. e-Pub 2025. PMID: 39941771.
- Brito-Dellan, N, Franco Vega, M, Ruiz, JI, Lu, M, Sahar, HN, Rajapakse, P, Lin, HY, Peterson, CB, Leal Alviarez, DJ, Altay, H, Tomy, S, Manzano, JM. Optimizing inpatient care for lung cancer patients with immune checkpoint inhibitor-related pneumonitis using a clinical care pathway algorithm. Supportive Care in Cancer 32(10), 2024. e-Pub 2024. PMID: 39283351.
- Sunny, J, Jimenez, S, Leal Alviarez, DJ, Faiz, S. Reexpansion Pulmonary Edema After Intrapleural Fibrinolytic Therapy. Annals of Internal Medicine Clinical Cases 2(5), 2023. e-Pub 2023.
- Suarez-Arroyo IJ, Rios-Fuller TJ, Feliz-Mosquea YR, Lacourt-Ventura M, Leal-Alviarez DJ, Maldonado-Martinez G, Cubano LA, Martinez-Montemayor MM. Ganoderma lucidum Combined with the EGFR Tyrosine Kinase Inhibitor, Erlotinib Synergize to Reduce Inflammatory Breast Cancer Progression. Journal of Cancer 7(5):500-511, 2016. e-Pub 2016. PMID: 26958085.
Other Articles
- Simgaqueba-Clavijo C, Odaro O, Gandhi A, Koom-Dadzie K, Musaelyan A, Dickson K, Chua R, Amoateng M, Tomy S, Leal Alviarez D, Phyu EM, Andersen C, Sheshadry A, Palaskas N L, Halm J, Manzano J Immunotherapy-Related Adverse Events and Clinical Outcomes in Adult Solid-Tumor Patients Admitted to an Onco-Hospitalist Medicine Service.
Abstracts
- Manzano JG, Franco-Vega, M, Lu M, Sahar H, Leal-Alviarez D, Altay H, Ruiz-Ignazio J, Tomy S, Brito-Dellan N. Improving the care of patients with lung cancer hospitalized with immune checkpoint inhibitor-related pneumonitis: Implementation of a clinical pathway algorithm. Abstract published at 2023 American Society of Clinical Oncology (ASCO) annual meeting, Chicago, IL, 2023. e-Pub 2023.
- Grace Manzano J, Leal Alviarez DJ, Lu M, Franco-Vega M, Sahar H, Ruiz JI, Altay H, Tomy S, Rajapakse P, Lin H, Brito-Dellan N. Enhancing the care of patients with immune checkpoint inhibitor-related pneumonitis through the development and implementation of a clinical pathway. MASCC/JASCC/ISOO 2023 Annual Meeting 31(399). e-Pub 2023.
- Manzano JG, Franco-Vega, M, Lu M, Ruiz JI, Sahar H, Leal-Alviarez D, Rajapakse P, Altay H, Tomy S, Lin H, Brito-Dellan N. Improving the care of patients with lung cancer hospitalized with immune checkpoint inhibitor-related pneumonitis: Implementation of a clinical pathway algorithm. Presented at MD Anderson Cancer Center, Division of Internal Medicine Research Retreat Poster Session, 2023. e-Pub 2023.
- Manzano JG, Franco-Vega, M, Lu M, Sahar H, Leal-Alviarez D, Altay H, Ruiz-Ignazio J, Tomy S, Brito-Dellan N. Enhancing the Coordination of Care for Hospitalized Patients with Suspected Immune Checkpoint Inhibitor (ICI)-related Pneumonitis through the Development and Implementation of a Hospital-Based Clinical Care Pathway. Presented at The University of Texas Austin and MD Anderson Collaborative Research Summit, Austin , Tx, 2022. e-Pub 2022.
- Bhamidipati, D, Jeyakumar, N, Leal, D, Nguyen, S, Pandey, Y, Ulhaq, O, Zhu, L. Inpatient Admission Medication Reconciliation, a Quality Improvement Project at MD Anderson Cancer Center. Presented at Baylor College of Medicine, Department of Medicine House staff Research Symposium, Houston, TX, 2020. e-Pub 2020.
- Leal DJ, Richards K, Robinson M. Rivaroxaban Induced Hypersensitivity Syndrome. Presented at Society of Hospital Medicine Annual Meeting, National Harbor, MD, 2019. e-Pub 2019.
- Manzano JG, Franco-Vega M, Lu M, Sahar H, Leal Alviarez DJ, Altay H, Ruiz-Ignazio J, Tomy S, Brito-Dellan N. Improving the care of patients with lung cancer hospitalized with immune checkpoint inhibitor-related pneumonitis: Implementation of a clinical pathway algorithm. 2023 American Society of Clinical Oncology (ASCO) annual meeting.
- Gandhi A, Koom-Dadzie K, Dickson K, Chua R, Bhise V, Amoateng M, Tomy S, Leal Alviarez D, Phyu EM, Bogdanich I, Halm J, Manzano J. Immunotherapy related adverse events and clinical outcomes in adult solid tumor cancer patients on immune checkpoint inhibitors admitted to a tertiary medical center hospitalist medicine service. SITC 39th Annual Meeting.
- Leal Alviarez DJ, Nieves-Jimenez H. Afferent loop syndrome in a young patient with extrahepatic cholangiocarcinoma: A challenging postoperative anatomy after complex hepatobiliary surgery. AACR Special Conference on The Rise in Early-Onset Cancers – Knowledge Gaps and Research Opportunities Meeting.
Patient Reviews
CV information above last modified January 07, 2026